You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恩華藥業(002262.SZ)董事會批准2021年度財務預算報吿
格隆匯 03-11 20:10

格隆匯 3 月 11日丨恩華藥業(002262.SZ)公佈,公司屆董事會第十五會議決議,審議通過了2021年度財務預算報吿》

經對比公司2020年度財務數據,公司在綜合考慮了宏觀經濟形勢的複雜多變、國家對醫藥產業監管力度不斷加大、市場競爭日趨激烈、藥品帶量招標、產品降價、成本上升、新型冠狀病毒疫情影響等諸多不確定性因素,編制了2021年度財務預算。公司預計2021可實現業務收入、利潤總額及淨利潤分別2020年審計後數據同口徑相比分別增長10%20%20%左右

上述財務預算、經營計劃、經營目標並不代表公司對2021年度的盈利預測,能否實現取決於內外部環境變化等多種因素,存在較大的不確定性,提請投資者特別注意。

該議案尚需提交公司2020年年度股東大會審議表決。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account